Choosing the right liver function tests is key for diagnosis. Alkaline phosphatase (ALP) and aspartate aminotransferase (GOT) detect disease, while adding gammaglutamyl transferase (GGTP) helps exclude it, guiding further investigation.
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Liver function tests (LFTs) are essential for diagnosing and managing hepatic diseases.
Selecting appropriate LFTs depends on the specific clinical context and diagnostic goals.
Purpose of the Study:
To outline the utility of various liver function tests in clinical practice.
To provide guidance on selecting and interpreting LFTs for disease detection and differential diagnosis.
Main Methods:
Review of established clinical guidelines and diagnostic algorithms for liver function testing.
Analysis of the diagnostic and exclusionary roles of specific liver enzymes and proteins.
Main Results:
Alkaline phosphatase (ALP) and aspartate aminotransferase (GOT) are primary tests for disease detection.
Combining ALP, GOT, and gammaglutamyl transferase (GGTP) aids in excluding liver disease.
A comprehensive panel including ALP, GOT, bilirubin, lactate dehydrogenase (LDH), albumin, globulin, and GGTP is valuable for routine differential diagnosis.
Prothrombin time is a key indicator of disease severity.
Interpretation is enhanced by analyzing enzyme predominance (ALP vs. GOT), enzyme relationships (LDH, ALP, bilirubin), and enzyme ratios (GGTP/ALP).
Conclusions:
The judicious selection and interpretation of LFTs are crucial for effective clinical decision-making.
Abnormalities in routine LFTs often necessitate more specialized diagnostic procedures.